Gold Nanostars as Multifunctional Platforms in Cancer Imaging and Therapy: Toward Radiotheranostic Applications
Pharmaceuticals · 17.09.2026 · 19 (9) · 1476
DOI: 10.3390/ph19091476 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceuticals, online erschienen am 17.09.2026. Verfasst von Ghazal Basirinia und 7 weiteren Autor:innen. Beteiligte Einrichtung: Ri.MED Foundation, Via Bandiera 11, 90133 Palermo, Italy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 89 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Health, Italian Ministry of Health.
Abstract (Originalsprache)
Gold nanostars (AuNSs) have emerged as promising platforms for cancer theranostics due to their distinctive optical and physicochemical properties, including strong plasmon resonance, tunable structure, and high photothermal conversion efficiency. These features support their use in various imaging modalities such as surface-enhanced Raman scattering (SERS), fluorescence, computed tomography (CT), magnetic resonance imaging (MRI), and photoacoustic imaging as well as in therapies like photothermal, photodynamic, and radiotheranostic treatments. The ability of GNS-based systems to integrate diagnostic and therapeutic functions in a single way facilitate real-time treatment monitoring and improves therapeutic accuracy. Furthermore, surface functionalization and the development of hybrid nanostructures can enhance tumor-targeting capability, biocompatibility, and performance in biological environments. However, several challenges such as limited tumor specificity, potential toxicity, complex interactions in biological systems, and difficulties in large-scale synthesis remain and limit their preclinical translation. Therefore, future efforts on optimizing nanoparticle stability, biodistribution, and safety while incorporating advanced strategies would support their preclinical and anticipated clinical application. In this review, we focus on the design, functionalization, and biomedical applications of gold nanostars in cancer imaging and therapy with future perspective in radiotheranostic strategies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Ri.MED Foundation, Via Bandiera 11, 90133 Palermo, Italy.
- Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, Molecular and Clinical Medicine, University of Palermo, 90127 Palermo, Italy.
- Department of Biomedicine, Neuroscience and Advanced Diagnostics (BiND), University of Palermo, 90127 Palermo, Italy.
- Advanced Diagnostic Imaging-INNOVA Project, Department of Radiological Sciences, A.R.N.A.S. Civico Di Cristina e Benfratelli Hospitals, P.zza N. Leotta 4, 90127 Palermo, Italy.
ORCID-Profile: Muhammad Ali, Albert Comelli, Pierpaolo Alongi, Domenico Di Raimondo, Antonino Tuttolomondo, Viviana Benfante
Förderung
- Ministry of Health
- Italian Ministry of Health
Zitieren
APA
Basirinia, G., Ali, M., Comelli, A., Arif, A., Alongi, P., Di Raimondo, D., Tuttolomondo, A., & Benfante, V. (2026). Gold Nanostars as Multifunctional Platforms in Cancer Imaging and Therapy: Toward Radiotheranostic Applications. Pharmaceuticals, 19(9), 1476. https://doi.org/10.3390/ph19091476
Vancouver
Basirinia G, Ali M, Comelli A, Arif A, Alongi P, Di Raimondo D, et al. Gold Nanostars as Multifunctional Platforms in Cancer Imaging and Therapy: Toward Radiotheranostic Applications. Pharmaceuticals. 2026;19(9):1476. doi:10.3390/ph19091476
BibTeX
@article{Basirinia2026,
author = {Basirinia, Ghazal and Ali, Muhammad and Comelli, Albert and Arif, Ayesha and Alongi, Pierpaolo and Di Raimondo, Domenico and Tuttolomondo, Antonino and Benfante, Viviana},
title = {Gold Nanostars as Multifunctional Platforms in Cancer Imaging and Therapy: Toward Radiotheranostic Applications},
journal = {Pharmaceuticals},
year = {2026},
volume = {19},
number = {9},
pages = {1476},
doi = {10.3390/ph19091476}
}
EUVIMED